Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)

Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1328
https://www.valueinhealthjournal.com/article/S1098-3015(16)32694-8/fulltext
Section Title : Disease-Specific Studies
Section Order : 1250
First Page : A577
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32694-8&doi=10.1016/j.jval.2016.09.1328
HEOR Topics :
Tags :
Regions :